The fundamental research areas of the Cell response and Regulation Program concern the biochemical mechanisms of signal transduction and the functional changes such signals induce. The major focus of this program is to understand how cells interact with their environment and how cells influence one another's function. This is a key aspect of growth control that affects metastasis and tumorigenesis. This broad Program has three subdivisions, which provides close interactions among program members. The subprograms are: 1) intracellular signal transduction, 2) cellular structure and function, 3) intercellular interactions. This Program of the Cancer Center is designed to explore new avenues of research to uncovered processes relevant to cancer tumorigenesis, and abnormal cell function. Thus, one goal of this program is to provide a sound biologic foundation for cancer-related research at the University of Utah by incorporating existing research programs and the expertise of the principal investigators into an integrated cancer-focus group. The second function of this Program is to act as an organized ancillary service for the clinical programs. The bench-to-bedside transfer of knowledge is fostered not only by the laboratory-based investigators of these physician scientists but also by their extended interaction with other basic scientists of this and other Cancer Center members. This program has 27 primary investigators, of which seven are physicians. The Departmental affiliations of Program members include Biochemistry, Biology, Bioengineering, Experimental Pathology, Human Genetics, Medicine, Oncological Sciences, Neurology, and Pharmacology and Toxicology. One member, Mark Keating, is a members of the Howard Hughes Medical Institute. Funding for these investigators arises from diverse, extramural sources that includes various institutes of the NIH, NSF, the American Chemical Society, the American Lung Association. There are over 300 publications from Program members work over the last funding period, showing that this is a productive group of investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA042014-14S1
Application #
6503932
Study Section
Project Start
2001-09-27
Project End
2002-04-30
Budget Start
Budget End
Support Year
14
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Ou, Judy Y; Fowler, Brynn; Ding, Qian et al. (2018) A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population. BMC Cancer 18:115
Liang, Wenjie; Yang, Pengfei; Huang, Rui et al. (2018) A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clin Cancer Res :
Vázquez-Arreguín, Karina; Maddox, Jessica; Kang, Jinsuk et al. (2018) BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism. Mol Cancer Res 16:439-452
Peres, Lauren C; Cushing-Haugen, Kara L; Anglesio, Michael et al. (2018) Histotype classification of ovarian carcinoma: A comparison of approaches. Gynecol Oncol 151:53-60
Zeng, Tao; Fleming, Aaron M; Ding, Yun et al. (2018) Nanopore Analysis of the 5-Guanidinohydantoin to Iminoallantoin Isomerization in Duplex DNA. J Org Chem 83:3973-3978
Himbert, Caroline; Ose, Jennifer; Nattenmüller, Johanna et al. (2018) Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study. Cancer Epidemiol Biomarkers Prev :
Madison, Bethany J; Clark, Kathleen A; Bhachech, Niraja et al. (2018) Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites. J Biol Chem 293:18624-18635
Arbeeva, Liubov S; Hanson, Heidi A; Arbeev, Konstantin G et al. (2018) How Well Does the Family Longevity Selection Score Work: A Validation Test Using the Utah Population Database. Front Public Health 6:277
Patel, Ami B; Lange, Thoralf; Pomicter, Anthony D et al. (2018) Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib. Oncotarget 9:17889-17894
De, Shrutokirti; Van Deren, Donn; Peden, Eric et al. (2018) Two distinct ontogenies confer heterogeneity to mouse brain microglia. Development 145:

Showing the most recent 10 out of 1193 publications